Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices --- United States, 2019
by from Morbidity and Mortality Weekly Report (MMWR) on (#4YB9P)
New Advisory Committee on Immunization Practices recommendations allow more flexibility for use of either tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) or tetanus and diphtheria toxoids (Td) vaccines in three scenarios where only Td had been previously recommended, most notably for tetanus booster doses recommended every 10 years for all adults.